MarketInOut Stock Screener Log In | Sign Up
 

Bluejay Diagnostics Inc

NASDAQ • Healthcare • Medical Devices • Quote as of 10/23/2026
Bluejay Diagnostics Inc stock price and volume chart

Company Profile

IndustryMedical Devices
SectorHealthcare
ExchangeNASDAQ
Market Capitalization2.81 mln
Float4.34 mln
Earnings Date11/06/2026

Piotroski F-Score

3 / 9
Below average

Relative Strength

7 / 100
Severely lagging

Debt / Equity

0.01
Debt-free

ROE

-127
Deeply negative

ROA

-102
Deeply negative

Business Description

Bluejay Diagnostics is a Massachusetts-based medical testing company founded in 2015. Its main product is the Symphony platform, a system that uses a handheld analyzer and disposable cartridges to quickly measure important biological markers in blood samples. The company currently offers a test for tracking inflammation in critically ill patients and is working to expand its offerings to include testing for heart attacks and heart failure.

Key Fundamentals

EPS-3.58
ROE-127
ROIC-386
ROA-102
Interest Cover-19,028
EBITDA, mln-7.09
EV / EBITDA0.79
EV / EBIT0.77

Quote Details

Last 0.585
Change -0.0438 (-6.97%)
Open 0.6315
Volume 39,741
Turnover 23,248
Average Volume 471,944

Financial Ratios

Leverage Ratio1.23
Current Ratio4.64
Price / Book0.18
Price / Tangible Book0.18
Debt / Equity0.01

Financial Strength

Piotroski F-Score 3 / 9
Short Ratio0.05
Short % of Float3.26

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -21.42% 3 / 100   
1 Month -38.42% 8 / 100   
2 Months -51.65% 8 / 100   
6 Months -69.21% 7 / 100   
1 Year -94.01% 4 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog